Go Deep
Electra Therapeutics, Inc.
Electra Therapeutics, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -29,051 | -3.2 | -20.52 | 0.02 | 828.76 |
| Oct 2026 | -29,051 | -3.2 | -20.52 | 0.02 | 828.76 |
| Oct 2026 | -28,841 | -3.2 | -20.19 | 0.02 | 816.37 |
| Oct 2026 | -29,140 | -3.3 | -20.66 | 0.02 | 835.33 |
| Oct 2026 | -29,499 | -3.4 | -21.22 | 0.02 | 855.97 |
| Oct 2026 | -29,798 | -3.5 | -21.69 | 0.02 | 873.12 |
Electra Therapeutics, Inc. Quarterly Results
Quarterly data isn't available for this company right now.
Electra Therapeutics, Inc. Revenue & Profit: Last 2 Years
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Net Profit | -61,975,000.0 | -24,786,000.0 |
| EPS | -1.8 | -0.6 |
Electra Therapeutics, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Total Assets | 99,368,000.0 | 19,420,000.0 |
| Total Liabilities | 129,694,000.0 | 122,681,000.0 |
| Total Equity | -30,326,000.0 | -103,261,000.0 |
Owes vs Owns
Electra Therapeutics, Inc. owed $1.25 for every $1 it owned in Jun 2026, down from $6.32 in Dec 2024.
| Period | Jun 2026 | Dec 2025 | Dec 2024 |
|---|---|---|---|
| Owes vs Owns | 1.25× | 1.31× | 6.32× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Electra Therapeutics, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 87.1%Fixed assets (tangible) 2.8%Other assets 9.9%
How it's funded — Dec 2025
Long-term debt 1.1%Payables 3.1%Other liabilities 95.2%
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Assets | ||
| Cash & short-term investments | 86.5 | 15.8 |
| Receivables | 0.2 | 0.1 |
| Inventory | 0.0 | 0.0 |
| Fixed assets (tangible) | 2.8 | 0.0 |
| Intangible assets | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 |
| Other assets | 9.8 | 3.6 |
| Liabilities & equity | ||
| Short-term debt | 0.6 | 0.0 |
| Long-term debt | 1.5 | 0.0 |
| Payables | 4.1 | 1.5 |
| Other liabilities | 123.5 | 121.1 |
| Shareholders' equity | -30.3 | -103.3 |
| Net tangible assets | -30.3 | -103.3 |
Electra Therapeutics, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Operating Activities | -60,484,000.0 | -26,003,000.0 |
| Investing Activities | -52,978,000.0 | 29,701,000.0 |
| Financing Activities | 131,683,000.0 | 0.0 |